FDA Warns of Cybersecurity Vulnerabilities of Hospira Infusion System
Warning that a security vulnerability could enable cyber attackers to take remote control of the system, the U.S. Food and Drug Administration on Friday recomended hospitals to discontinue using Hospira Inc’s Symbiq infusion system. It comes at a time of rising concerns...
Posted On Aug 03 2015